Global Large Volume Wearable Injectors Market Growth 2023-2029

Global Large Volume Wearable Injectors Market Growth 2023-2029

Product Code:458396

Published Date: Feb 08,2023

Pages: 107

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.

LPI (LP Information)' newest research report, the “Large Volume Wearable Injectors Industry Forecast” looks at past sales and reviews total world Large Volume Wearable Injectors sales in 2022, providing a comprehensive analysis by region and market sector of projected Large Volume Wearable Injectors sales for 2023 through 2029. With Large Volume Wearable Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Large Volume Wearable Injectors industry.

This Insight Report provides a comprehensive analysis of the global Large Volume Wearable Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Large Volume Wearable Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Large Volume Wearable Injectors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Large Volume Wearable Injectors and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Large Volume Wearable Injectors.

The global Large Volume Wearable Injectors market size is projected to grow from US$ 1439 million in 2022 to US$ 11550 million in 2029; it is expected to grow at a CAGR of 11550 from 2023 to 2029.

The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.

This report presents a comprehensive overview, market shares, and growth opportunities of Large Volume Wearable Injectors market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Electronical Injectors
    Mechanical Injectors
    Others

Segmentation by application
    Cancer Treatment
    Auto-immune Treatment
    Blood Disorders Treatment
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    West Pharmaceuticals
    Unilife Corporation
    CeQur
    Sensile Medical AG
    BD Medical
    Enable Injections
    Roche Laboratories
    scPharmaceuticals
    SteadyMed Therapeutics
    Johnson & Johnson

Key Questions Addressed in this Report
What is the 10-year outlook for the global Large Volume Wearable Injectors market?
What factors are driving Large Volume Wearable Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Large Volume Wearable Injectors market opportunities vary by end market size?
How does Large Volume Wearable Injectors break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?